Sputnik V is the world’s first registered vaccine based on a well-studied human adenoviral vector-based platform. Sputnik V is one of the three vaccines in the world with efficacy of over 90%. – Read More
India's production and exports of Russia's Sputnik COVID-19 vaccines are expected to slow further following U.S. sanctions on Russia's sovereign wealth fund that promotes...
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces that the Russian Sputnik V vaccine against coronavirus has been granted full permanent...
Earlier, the Russian Ministry of Economic Development announced that Russia had made agreements with six Chinese manufacturers for the production of Russian coronavirus vaccines...
Argentina has displayed an interest in the nasal form of Russia's Sputnik V coronavirus vaccine and other Russian developments for treating and preventing COVID-19,...
The Gamaleya National Research Center of Epidemiology and Microbiology (Gamaleya Center) and the Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund, investor in...